(Q39361249)

11 September 2017

Resistance to rifampicin and isoniazid in strains of Mycobacterium tuberculosis (English)

1 reference

Mycobacterium tuberculosis

11 September 2017

0 references

1 reference

0 references

Siddiqi SH

1

1 reference

11 September 2017

Aziz A

series ordinal

2

1 reference

11 September 2017

Reggiardo Z

series ordinal

3

1 reference

11 September 2017

Middlebrook G

series ordinal

4

1 reference

11 September 2017

language of work or name

English

0 references

publication date

1 August 1981

1 reference

Journal of Clinical Pathology

11 September 2017

1 reference

11 September 2017

34

1 reference

11 September 2017

8

1 reference

11 September 2017

927-929

1 reference

Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=493987

Bactericidal activity in vitro and in the guinea-pig of isoniazid, rifampicin and ethambutol

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=493987

Automatable radiometric detection of growth of Mycobacterium tuberculosis in selective media

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=493987

Rifampin: a semisynthetic derivative of rifamycin--a prototype for the future

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=493987

In vitro activity of rifampin against the H37RV strain of Mycobacterium tuberculosis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=493987

Antituberculous activity of rifampin in vitro and in vivo and the concentrations attained in human blood

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=493987

The antimycobacterial activity of rifampin

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=493987

[Virulence of rifampicin-resistant tubercle bacilli for experimental animals (preliminary report)]

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=493987

The pattern of resistance development to rifampicin in mycobacterium tuberculosis

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=493987

Some comparative aspects of rifampicin and isoniazid

17 June 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/6792243

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/JCP.34.8.927

1 reference

11 September 2017

1 reference

11 September 2017

1 reference